Synopsys Inc.: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-07-05
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
12
Removed
9
Modified
15
Unchanged
🟢 New in Current Filing Severity8/10Det 8

We or our directors or officers are subject to litigation proceedings, which are expensive, could divert management attention and harm our business.

We are subject to legal claims or regulatory matters involving stockholder, consumer, employment, customer, supplier, competition and other issues on a global basis. Litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could…

Read full text

We are subject to legal claims or regulatory matters involving stockholder, consumer, employment, customer, supplier, competition and other issues on a global basis. Litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages or, in cases for which injunctive relief is sought, an injunction prohibiting us from manufacturing or selling one or more products. If we were to receive an unfavorable ruling on a matter, our business and operating results could be materially harmed. For example, we are currently named as a defendant in recently filed securities class action complaints. The stock market in general, and Nasdaq and technological companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of companies. The market price of our common stock is or may be volatile. In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. In addition, certain of our directors and officers may be involved in ongoing securities or other lawsuits, including in the context of their roles with other public companies, and our directors or officers may in the future become 27 27 27 Table of Contents Table of Contents involved in such litigation. Securities litigation, including the cost to defend against, and any potential adverse outcome resulting from any such proceeding, can be expensive, time-consuming, damage our reputation and divert our management’s and board of directors’ attention from other business concerns, which could seriously harm our business. As noted above, on October 31, 2025 and November 25, 2025, respectively, two shareholder class action complaints were filed in the United States District Court for the Northern District of California against Synopsys and certain of our current directors and officers. Both complaints allege that certain material misstatements or omissions related to the performance of our Design IP segment were made in violation of federal securities laws. There is no guarantee that we will be successful in our efforts to defend against these complaints. Further information regarding certain of these matters is contained in Part II, Item 1, Legal Proceedings of this Annual Report.

🔴 No Match in Current Filing Business Operations Risks 🔒
🟡 Modified Uncertainty in the macroeconomic environment, and its potential impact on the semiconductor and electronics industries, may negatively affect our business, operating results and financial condition. 🔒
🔴 No Match in Current Filing Liquidity requirements in our U.S. operations may require us to raise cash in uncertain capital markets, which could negatively affect our financial condition. 🔒
🔴 No Match in Current Filing We may fail to complete the Ansys Merger or may not complete it on the terms described herein or in our other filings with the SEC. 🔒
🔴 No Match in Current Filing The Ansys Merger is subject to the receipt of governmental approvals that may impose conditions that could have an adverse effect on us or, if not obtained, could prevent completion of the Ansys Merger. 🔒
🔴 No Match in Current Filing Failure to realize the benefits expected from the Ansys Merger could adversely affect our business, operating results and financial condition. 🔒
🔴 No Match in Current Filing We may be subject to litigation proceedings that could harm our business. 🔒
🔴 No Match in Current Filing Industry Risks 🔒
🔴 No Match in Current Filing Risks Related to the Ansys Merger 🔒
🔴 No Match in Current Filing General Risks 🔒
🔴 No Match in Current Filing As a result of the Ansys Merger, we anticipate that the scope and size of our operations and business will substantially change and will result in certain incremental risks to us, including increased competition. We may not realize the full expected benefits of the Ansys Merger. 🔒
🟡 Modified The global nature of our operations exposes us to increased risks and compliance obligations. 🔒
🟡 Modified We are subject to governmental export and import requirements that could subject us to liability and restrict our ability to sell our products and services, which could impair our ability to compete in international markets. 🔒
🔴 No Match in Current Filing Risk Factor Summary 🔒
🔴 No Match in Current Filing Legal and Regulatory Risks 🔒
🟡 Modified Our operating results may fluctuate in the future, which may adversely affect our stock price. 🔒
🟡 Modified Our hardware products, which primarily consist of prototyping and emulation systems, subject us to distinct risks. 🔒
🟡 Modified The growth of our business depends primarily on the semiconductor and electronics industries. 🔒
🟡 Modified Our significant debt may limit our financial flexibility. 🔒
🟡 Modified Our business is subject to evolving corporate governance and public disclosure regulations and expectations that could expose us to numerous risks. 🔒
🟡 Modified The covenants contained in the agreements governing our indebtedness may impose restrictions on us and certain of our subsidiaries that may affect our ability to operate our businesses. 🔒
21 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get full access — from $29/month Already a Pro subscriber? View full diff →